Head down tilt 15° (HDT15°) in the hyperacute phase of experimental intracerebral haemorrhage (ICH) does not worsen early outcome.
Why this matters
HDT15° applied before recanalization can increase collateral flow and improve outcome in experimental ischemic stroke.
Development and implementation of a “collateral therapeutic” is a major objective in stroke research. With its simplicity and low cost, HDT15° represents a good candidate as a collateral therapeutic that can be applied by emergency services.